Building drug delivery into tissue engineering

Nature Reviews Drug Discovery

Volumn 1, Issue 3, 2002, Pages 177-186

  Saltzman, W Mark ^a   Olbricht, William L ^a  

^a Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; LIPOSOME; MACROGOL; MICROSPHERE; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN; POLYLACTIC ACID; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TANTALUM; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

BIOTECHNOLOGY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED RELEASE FORMULATION; CORNEA ULCER; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TISSUE LEVEL; ENCAPSULATION; ENDOTHELIUM CELL; FLUID TRANSPORT; FOOD AND DRUG ADMINISTRATION; HUMAN; NEEDLE; OSMOTIC PUMP; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SIDE EFFECT; SKIN ULCER; STROKE; TECHNOLOGY; TISSUE DISTRIBUTION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; VASCULAR ENDOTHELIUM; METHODOLOGY; PHYSIOLOGY; REGENERATION;

DRUG DELIVERY SYSTEMS; HUMANS; REGENERATION; TISSUE ENGINEERING;

EID: 0036490227     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd744     Document Type: Review

References (92)

1. Langer, R. & Vacanti, J. P. Tissue engineering. Science 260, 920-932(1993).
2. Singer, A. J. & Clark, R. A. F. Cutaneous wound healing. New Engl. J. Med. 341, 738-746 (1999).
3. Black, A. F., Berthod, F., L'Heureux, N., Germain, L. & Auger, F. A. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 12, 1331-1340 (1998).
4. Wolpert, L. Positional information and pattern formation. Curr. Top. Dev. Biol. 6, 183-224 (1971).
5. Gurdon, J. B. & Bourillot, P.-Y. Morphogen gradient interpretation. Nature 413, 797-803 (2001).
6. Peppas, N. A. & Langer, R. New challenges in biomaterials. Science 263, 1715-1720 (1994).
7. Ratner, B., Hoffman, A., Schoen, F. & Lemons, J. (eds) Biomaterials Science: an Introduction to Materials in Medicine (Academic, San Diego, 1996).
8. Saltzman, W. M. Drug Delivery: Engineering Principles for Drug Therapy (Oxford Univ. Press, New York, 2001).
9. Hoffman, D., Wahlberg, L. & Aebischer, P. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp. Neurol. 110, 39-44 (1990).
10. Mahoney, M. J. & Saltzman, W. M. Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nature Biotechnol. 19, 934-939 (2001).
11. Craig, C. G. et al. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J. Neurosci. 16, 2649-2658 (1996).
12. Brown, L., Siemer, L., Munoz, C., Edelman, E. & Langer, R. Controlled release of insulin from polymer matrices: control of diabetes in rats. Diabetes 35, 692-697 (1986).
13. Edelman, E. R., Mathiowitz, E., Langer, R. & Klagsbrun, M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12, 619-626 (1991).
14. Murray, J., Brown, L., Langer, R. & Klagsburn, M. A micro sustained release system for epidermal growth factor. In Vitro 19, 743-748 (1983).
15. Krewson, C. E., Klarman, M. & Saltzman, W. M. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res. 680, 196-206 (1995).
16. Saltzman, W. M. & Langer, R. Transport rates of proteins in porous polymers with known microgeometry. Biophys. J. 55, 163-171 (1989).
17. Radomsky, M. L., Whaley, K. J., Cone, R. A. & Saltzman, W. M. Controlled vaginal delivery of antibodies in the mouse. Biol. Reprod. 47, 133-140 (1992).
18. Saltzman, W. M. Antibodies for treating and preventing disease: the potential role of polymeric controlled release. Crit. Rev. Ther. Drug Carrier Syst. 10, 111-142 (1993).
19. Sherwood, J. K., Zeitlin, L., Whaley, K. J., Cone, R. A. & Saltzman, W. M. Controlled release of antibodies for sustained topical passive immunoprotection of female mice against genital herpes. Nature Biotechnol. 14, 468-471 (1996).
20. Pries, I. & Langer, R. A single-step immunization by sustained antigen release. J. Immunol. Methods 28, 193-197 (1979).
21. Wyatt, T. L., Whaley, K. J., Cone, R. A. & Saltzman, W. M. Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina. J. Control. Release 50, 93-102 (1998).
22. Luo, D., Woodrow-Mumford, K., Belcheva, N. & Saltzman, W. M. Controlled DNA delivery systems. Pharm. Res. 16, 1300-1308 (1999).
23. Camarata, P. J., Suryanarayanan, R. & Turner, D. A. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 30, 313-319 (1992).
24. Krewson, C. E., Dause, R. B., Mak, M. W. & Saltzman, W. M. Stabilization of nerve growth factor in polymers and in tissues. J. Biomater. Sci. 8, 103-117 (1996).
25. Gombotz, W. R., Pankey, S. C., Bouchard, L. S., Ranchalis, J. & Puolakkainen, P. Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration. J. Biomater. Sci. Polym. Edn 5, 49-63 (1993).
26. Johnson, O. L. et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 2, 795-799 (1996).
27. Mathiowitz, E., Saltzman, W. M., Domb, A., Dor, P. & Langer, R. Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal. J. Appl. Polym. Sci. 35, 755-774 (1988).
28. Sherwood, J. K., Dause, R. B. & Saltzman, W. M. Controlled antibody delivery systems. Bio/Technology 10, 1446-1449 (1992).
29. Cleland, J. L. in Vaccine Design: the Subunit and Adjuvant Approach (eds Powell, M. F. & Newman, M. J.) 439-462 (Plenum, New York, 1995).
30. Marx, P. A. et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323-1327 (1993).
31. Whittum-Hudson, J. A., Prendergast, R. A., Saltzman, W. M., An, L. L. & MacDonald, A. B. Oral immunization with an anti-idiotypic antibody to the exolipid antigen protects against experimental Chlamydia trachomatis infection. Nature Med. 2, 1116-1121 (1996).
32. Shea, L. D., Smiley, E., Bonadio, J. & Mooney, D. J. DNA delivery from polymer matrices for tissue engineering. Nature Biotechnol. 17, 551-554 (1999).
33. Puolakkainen, P. A. et al. The enhancement in wound healing by transforming growth factor-β1 depends on the topical delivery system. J. Surg. Res. 58, 321-329 (1995).
34. Hill-West, J. L., Dunn, R. C. & Hubbell, J. A. Local release of fibrinolytic agents for adhesion prevention. J. Surg. Res. 59, 759-763 (1995).
35. Richardson, T. P., Peters, M. C., Ennett, A. B. & Mooney, D. J. Polymeric system for dual growth factor delivery. Nature Biotechnol. 19, 1029-1034 (2001).
36. Hubbell, J. A. Biomaterials in tissue engineering. Bio/Technology 13, 565-576 (1995).
37. Baldwin, S. P. & Saltzman, W. M. Polymers for tissue engineering. Trends Polym. Sci. 4, 177-182 (1996).
38. Freed, L. et al. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J. Biomed. Mater. Res. 27, 11-23 (1993).
39. Vacanti, C. A., Langer, R., Schloo, B. & Vacant, J. P. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast. Reconstr. Surg. 88, 753-759 (1991).
40. Uyama, S., Kaufman, P. M., Takeda, T. & Vacanti, J. P. Delivery of whole liver-equivalent hepatocyte mass using polymer devices and hepatotrophic stimulation. Transplantation 55, 932-935 (1993).
41. Lo, H., Ponticello, M. & Leong, K. Fabrication of controlled release biodegradable foams by phase separation. Tissue Eng. 1, 15 (1995).
42. Mann, B. K., Gobin, A. S., Tsai, A. T., Schmedlen, R. H. & West, J. L. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 22, 3045-3051 (2001).
43. Carbonetto, S. T., Gruver, M. M. & Turner, D. C. Nerve fiber growth on defined hydrogel substrates. Science 216, 897-899 (1982).
44. Mann, B. K., Schmedlen, R. H. & West, J. L. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22, 439-444 (2001).
45. Kuhl, P. R. & Griffith, L. G. Tethered epidermal growth factor as a paradigm of growth factor-induced stimulation from the solid phase. Nature Med. 2, 1022-1027 (1996).
46. Belcheva, N. B., Woodrow-Mumford, K., Mahoney, M. J. & Saltzman, W. M. Synthesis and characterization of polyethylene glycol-mouse nerve growth factor conjugates. Bioconjug. Chem. 6, 932-937 (1999).
47. Knusli, C., Delgado, C., Malik, F. & Francis, G. E. Br. J. Haematol. 82, 654 (1982).
48. Bentz, H., Schroeder, J. H. & Estridge, T. D. Improved local delivery of TGF-β2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. J. Biomed. Mater. Res. 39, 539-548 (1998).
49. Sakiyama-Elbert, S. E. & Hubbell, J. A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J. Control. Release 69, 149-158 (2000).
50. Sakiyama-Elbert, S. E., Panitch, A. & Hubbell, J. A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 15, 1300-1302 (2001).
51. Dario, P., Carrozza, M. C., Benvenuto, A. & Menciassi, A. Micro-Systems in biomedical applications. J. Micromech. Microeng. 10, 235-244 (2000).
52. Whitesides, G. M. & Stroock, A. D. Flexible methods for microfluidics. Physics Today 54, 42-46 (2001).
53. Paul, P. H., Garguilo, M. G. & Rakestraw, D. J. Imaging of pressure- and electrokinetically driven flows through open capillaries. Anal. Chem. 70, 2459-2467 (1998).
54. Paul, P. H., Arnold, D. W., Neyer, D. W. & Smith, K. B. in Micro Total Analysis Systems 2000 (eds Van den Berg, A., Olthius, W. & Bergveld, P.) 583-590 (Kluwer Academic, The Netherlands, 2000).
55. Quake, S. R. & Scherer, A. From micro- to nanofabrication with soft materials. Science 290, 1536-1540 (2000).
56. Hammarback, J. A., Palm, S. L., Furcht, L. T. & Letourneau, P. C. Guidance of neurite outgrowth by pathways of substratum-adsorbed laminin. J. Neurosci. Res. 13, 213-220 (1985).
57. Folch, A. & Toner, M. Microengineering of cellular interactions. Annu. Rev. Biomed. Eng. 2, 227-256 (2000).
58. Takayama, S. et al. Patterning cells and their environments using multiple laminar fluid flows in capillary networks. Proc. Natl Acad. Sci. 96, 5545-5548 (1999).
59. Chiu, D. T. et al. Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc. Natl Acad. Sci. 97, 2408-2413 (2000).
60. Thorsen, T., Roberts, R. W., Arnold, F. H. & Quake, S. R. Dynamic pattern formation in a vesicle-generating microluidic device, Phys. Rev. Lett. 86, 4163-4166 (2001).
61. McAllister, D. V., Allen, M. G. & Prausnitz, M. R. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. Eng. 2, 289-313 (2000).
62. Chun, K., Hashiguchi, G., Toshiyoshi, H. & Fujita, H. Fabrication of array of hollow microcapillaries used for injection of genetic materials into animal/plant cells. Jpn. J. Appl. Phys. 38, 279-281 (1999).
63. Chen, J. & Wise, K. D. A multichannel neural probe for selection chemical delivery at the cellular level. IEEE Trans. Biomed. Eng. 44. 760-769 (1997).
64. Brazzle, J. D., Paputsky, I. & Frazier, A. B. Fluid-coupled hollow metalic micromachined needle arrays. Proc. SPIE Conf. Microfluidic Dev. Syst. 3515, 116-124 (1998).
65. Brazzle, J. D., Mohanty, S. & Frazier, A. B. Hollow metallic micromachined needles with multiple output ports. Proc. SPIE Conf. Microfluidic Dev. Syst. 3877, 257-266 (1999).
66. Santini, J. T., Richards, A. C., Scheidt, R., Cima, M. J. & Langer, R. Microchips as controlled drug-delivery devices. Angew. Chem. Int. Edn Engl. 39, 2396-2407 (2000).
67. Fukuchi-Shimogori, T. & Grove, E. A, Neocortex patterning by the secreted signaling molecule FGF8. Science 294, 1071-1074 (2001).
68. Farinas, I. et al. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J. Neurosci. 21, 6170-6180 (2001).
69. Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000).
70. Radomsky, M. L., Whaley, K. J., Cone, R. A. & Saltzman, W. M. Macromolecules released from polymers: diffusion into unstirred fluids. Biomaterials 11, 619-624 (1990).
71. Beaty, C. E. & Saltzman, W. M. Controlled growth factor delivery induces differental neurite outgrowth in three-dimensional cell cultures. J. Control. Release 24, 15-23 (1993).
72. Driever, W. & Nusslein-Volhard, C. A gradient of Bicoid protein in Drosophila embryos. Cell 54, 83-93 (1988).
73. Krewson, C. E. & Saltzman, W. M. Transport and elimination of recombinant human NGF during long-term delivery to the brain. Brain Res. 727, 169-181 (1996).
74. Mahoney, M. J. & Saltzman, W. M. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. Proc. Natl Acad. Sci. USA 96, 4536-4539 (1999).
75. Mak, M., Fung, L., Strasser, J. F. & Saltzman, W. M. Distribution of drugs following controlled delivery to the brain interstitium. J. of Neurooncol. 26, 91-102 (1995).
76. Kuo, P. Y., Sherwood, J. K. & Saltzman, W. M. Topical antibody delivery systems produce sustained levels in mucosal tissues and blood. Nature Biotechnol 16, 163-167 (1998).
77. Mahoney, M. J. & Saltzman, W. M. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J. Pharm. Sci. 85, 1276-1281 (1996).
78. Morrison, P. F., Laske, D. W., Bobo, H., Oldfield, E. H. & Dedrick, R. L. High-low microinfusion: tissue penetration and pharmacodynamics. Am. J. Physiol. 266, R292-R305 (1994).
79. Lonser, R. R., Weil, R. J., Morrison, P. F, Governale, L. S. & Oldfield, E. H. Direct convection delivery of macromolecules to peripheral nerves. J. Neurosurg. 89, 610-615 (1998).
80. Lonser, R. R. et al. Direct convective delivery of macromolecules to the spinal cord. J. Neurosurg. 89, 612-622 (1998).
81. Hewitt, C. W. & Black, K. S. Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants. Transplant. Proc. 28, 922-923 (1996).
82. McArthur, J. C. et al. A Phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 54, 1080-1088 (2000).
83. Lambiase, A., Rama, P., Bonini, S., Caprioglio, G. & Aloe, L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. New Engl. J. Med. 338, 1174-1180 (1998).
84. Saltzman, W. M. & Radomsky, M. L. Drugs released from polymers: diffusion and elimination in brain tissue. Chem. Eng. Sci. 46, 2429-2444 (1991).
85. Nor, J. E. et al. Engineering and characterization of functional microvessels in immunodeficient mice. Lab. Invest. 81, 453-463 (2001).
86. Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96 (2000).
87. Schechner, J. S. et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc. Natl Acad. Sci. USA 97, 9191-9196 (2000).
88. Saito, N. et al. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nature Biotechnol. 19, 332-335 (2001).
89. Kale, S. et al. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nature Biotechnol. 18, 954-958 (2000).
90. Hunziker, E. B. Growth-factor-induced healing of partial-thickness defects in adult articular cartilage. Osteoarthritis Cartilage 9, 22-32 (2001).
91. Schense, J. C., Bloch, J., Aebischer, P. & Hubbell, J. A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nature Biotechnol. 18, 415-419 (2000).
92. Poznansky, M. C. et al. Efficient generation of human T cells from a tissue-engineered thymic organoid. Nature Biotechnol. 18, 729-734 (2000).